Article
Perhexiline.
Cardiovascular drug reviews - 1 Jan 2007
Ashrafian Houman, Horowitz John D, Frenneaux Michael P
Abstract excerpt
Perhexiline, 2-(2,2-dicyclohexylethyl)piperidine, was originally developed as an anti-anginal drug in the 1970s. Despite its success, its use diminished due to the occurrence of poorly understood side effects including neurotoxicity and hepatotoxicity in a small proportion of patients. Recently, perhexiline's mechanism of action and the molecular basis of its toxicity have been elucidated. Perhexiline reduces...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
